{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:13:11Z","timestamp":1780704791005,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.humpath.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T05:44:29Z","timestamp":1554097469000},"page":"66-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement"],"prefix":"10.1016","volume":"88","author":[{"given":"Snjezana","family":"Dogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte K.Y.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Edelweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasinya N.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Zehir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Drilon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc G.T.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina R.","family":"Antonescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Katabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge S.","family":"Reis-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2019.03.004_bb0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00301495","article-title":"Salivary duct carcinoma. A group of salivary gland tumors analogous to mammary duct carcinoma","volume":"192","author":"Kleinsasser","year":"1968","journal-title":"Arch Klin Exp Ohren Nasen Kehlkopfheilkd"},{"key":"10.1016\/j.humpath.2019.03.004_bb0010","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ijc.31353","article-title":"A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from the Netherlands","volume":"143","author":"Boon","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2019.03.004_bb0015","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.humpath.2009.12.011","article-title":"Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases","volume":"41","author":"Katabi","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2019.03.004_bb0020","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/PAS.0000000000000410","article-title":"Molecular characterization of apocrine salivary duct carcinoma","volume":"39","author":"Chiosea","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.03.004_bb0025","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1158\/1078-0432.CCR-16-0637","article-title":"Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast Cancer","volume":"22","author":"Dalin","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2019.03.004_bb0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-integrated mutation profiling of actionable Cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2019.03.004_bb0035","series-title":"World Health Organization classification of head and neck Tumours","first-page":"173","author":"El-Naggar","year":"2017"},{"key":"10.1016\/j.humpath.2019.03.004_bb0040","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","article-title":"Absolute quantification of somatic DNA alterations in human cancer","volume":"30","author":"Carter","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.humpath.2019.03.004_bb0045","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and impact of subclonal mutations in chronic lymphocytic leukemia","volume":"152","author":"Landau","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2019.03.004_bb0050","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1158\/1078-0432.CCR-15-2840","article-title":"The genomic landscape of male breast cancers","volume":"22","author":"Piscuoglio","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2019.03.004_bb0055","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1158\/1078-0432.CCR-16-2857","article-title":"The landscape of somatic genetic alterations in metaplastic breast carcinomas","volume":"23","author":"Ng","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2019.03.004_bb0060","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.humpath.2019.03.004_bb0065","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/2159-8290.CD-15-0412","article-title":"Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy","volume":"5","author":"Murugaesu","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1016\/j.humpath.2019.03.004_bb0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/path.4691","article-title":"Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations","volume":"238","author":"Guerini-Rocco","year":"2016","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2019.03.004_bb0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5858\/arpa.2013-0953-SA","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"138","author":"Wolff","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2019.03.004_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2019.03.004_bb0085","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/2159-8290.CD-12-0470","article-title":"A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition","volume":"3","author":"Whittaker","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.humpath.2019.03.004_bb0090","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1073\/pnas.1014835108","article-title":"Cyclin E amplification\/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients","volume":"108","author":"Scaltriti","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.humpath.2019.03.004_bb0095","doi-asserted-by":"crossref","first-page":"64431","DOI":"10.18632\/oncotarget.7043","article-title":"Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer","volume":"7","author":"de Melo Gagliato","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2019.03.004_bb0100","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/cncr.30179","article-title":"Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations","volume":"122","author":"Chiosea","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2019.03.004_bb0105","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1158\/1078-0432.CCR-03-0253","article-title":"HER2 expression in salivary gland carcinomas: dependence on histological subtype","volume":"10","author":"Glisson","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2019.03.004_bb0110","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1634\/theoncologist.2012-0369","article-title":"Trastuzumab for the treatment of salivary duct carcinoma","volume":"18","author":"Limaye","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.humpath.2019.03.004_bb0115","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hed.20614","article-title":"Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy","volume":"29","author":"Nabili","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.humpath.2019.03.004_bb0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1158\/2159-8290.CD-12-0349","article-title":"Activating HER2 mutations in HER2 gene amplification negative breast cancer","volume":"3","author":"Bose","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.humpath.2019.03.004_bb0125","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.6004\/jnccn.2015.0131","article-title":"HER2-mutated breast cancer responds to treatment with single-agent Neratinib, a second-generation HER2\/EGFR tyrosine kinase inhibitor","volume":"13","author":"Ben-Baruch","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.humpath.2019.03.004_bb0130","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.6004\/jnccn.2015.0132","article-title":"Prolonged response to trastuzumab in a patient with HER2-nonamplified breast cancer with elevated HER2 dimerization harboring an ERBB2 S310F mutation","volume":"13","author":"Chumsri","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.humpath.2019.03.004_bb0135","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2559.2012.04252.x","article-title":"Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes","volume":"61","author":"Di Palma","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2019.03.004_bb0140","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1158\/1078-0432.CCR-12-1842","article-title":"Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment","volume":"19","author":"Nardi","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2019.03.004_bb0145","doi-asserted-by":"crossref","first-page":"e727","DOI":"10.1200\/JCO.2011.36.2095","article-title":"Salivary duct carcinoma: targeting the phosphatidylinositol 3-kinase pathway by blocking mammalian target of rapamycin with temsirolimus","volume":"29","author":"Piha-Paul","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2019.03.004_bb0150","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1021\/acs.jmedchem.5b01655","article-title":"Discovery of bifunctional oncogenic target inhibitors against allosteric mitogen-activated protein kinase (MEK1) and phosphatidylinositol 3-kinase (PI3K)","volume":"59","author":"Van Dort","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.humpath.2019.03.004_bb0155","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2019.03.004_bb0160","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S1470-2045(11)70232-7","article-title":"Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis","volume":"12","author":"Shaw","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2019.03.004_bb0165","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature15258","article-title":"Alternative transcription initiation leads to expression of a novel ALK isoform in cancer","volume":"526","author":"Wiesner","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2019.03.004_bb0170","doi-asserted-by":"crossref","first-page":"120ra117","DOI":"10.1126\/scitranslmed.3003316","article-title":"Mechanisms of acquired crizotinib resistance in ALK-rearranged lung cancers","volume":"4","author":"Katayama","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.humpath.2019.03.004_bb0175","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jamaoto.2014.1998","article-title":"Salivary gland cancer in BRCA-positive families: a retrospective review","volume":"140","author":"Shen","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719300498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719300498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T02:43:18Z","timestamp":1607136198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817719300498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":35,"alternative-id":["S0046817719300498"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2019.03.004","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}